FRAXA Fellowship

Ends on 1 February 2025

FRAXA ‘s mission is to find specific treatments and ultimately a cure for Fragile X syndrome. We aim to bring practical treatment into current medical practice as quickly as possible; we prioritize projects that have a clear practical application and the results of which will be shared in a timely fashion.

FRAXA awards two types of funding:

  1. Clinical Trial applications are accepted and reviewed on a revolving basis, so there is no application deadline. Our #1 priority is to fund clinical trials, while still continuing to support worthwhile translational research and other early-stage work.
  2. FRAXA Fellowship applications are due on February 1 each year.

More details

https://www.fraxa.org/fragile-x-research/grant-application/